Vanda Pharmaceuticals to Present Data on Iloperidone at the 2007,American Psychiatric Association Annual Meeting ( t of excessive sleepiness that is in a ...)

(Date:10/8/2008)... Arizona Heart Institute Pioneers Research Th...PHOENIX, Oct. 8 /- Nationally, over 3...nd a new lease on life. Sadly, only half,of those ...h at Arizona,Heart Institute (AHI) is paving the w... patients., To view the Multimedia News Release, ...

(Date:10/8/2008)... PERSEUS clinical program to evaluate TAXUS(R) El... Stent, NATICK, Mass., Oct. 8 /PRNewswir...E: BSX ) today announced that it has completed en...e the Company,s third-generation,TAXUS(R) Element(...,clinical program has enrolled nearly 1,500 patien...

(Date:10/8/2008)... -- Exploratory study shows clinical improvem...tension (PAH), -- Current treatment options hav...dly progressive and incurable blood vessel disease... for treatment of certain cancers, known to i... to further explore potential of imatinib mesylate...

(Date:10/7/2008)... Study evaluates the efficacy of new device for d...missed during colonoscopy, ORLANDO, Fla., Oct. 7 ...nterology Annual Scientific Meeting in Orlando (AC...x, MD presented results from a,multi-institutional... Third,Eye(R) Retroscope(R), a new device that is ...

[0] Video: Answer to Curing a Failing Heart May Exist in Body's Own 'Do-It-Yourself' Repair Kit [0] Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent [0] Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease [0] National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon

...Call/ -- Bristol-Myers,Squibb Company (NYSE: BMY) ... showed that treatment with Baraclude (entecavir),...fovir at 48 weeks,-- a result that was also seen a...rom an open-label, randomized viral kinetics study...en (HBeAg),positive patients were presented at the...

.../ -- Data presented,today at a major medical meeti...ts administered once-daily for five days is as,eff...00 mg) for 10,days for the treatment of complicate...ephritis (AP). , Ortho-McNeil, Inc., the company t...ta during a scientific session at the annual,meeti...

Other Medicine Technology:Baraclude (Entecavir) Treatment Demonstrated Greater Viral Load,Reduction Compared to Adefovir at 48 Weeks in Study of,Antiviral-Naive Chronic Hepatitis B E-Antigen Positive Patients 2 Baraclude (Entecavir) Treatment Demonstrated Greater Viral Load,Reduction Compared to Adefovir at 48 Weeks in Study of,Antiviral-Naive Chronic Hepatitis B E-Antigen Positive Patients 3 Baraclude (Entecavir) Treatment Demonstrated Greater Viral Load,Reduction Compared to Adefovir at 48 Weeks in Study of,Antiviral-Naive Chronic Hepatitis B E-Antigen Positive Patients 4 Baraclude (Entecavir) Treatment Demonstrated Greater Viral Load,Reduction Compared to Adefovir at 48 Weeks in Study of,Antiviral-Naive Chronic Hepatitis B E-Antigen Positive Patients 5 Baraclude (Entecavir) Treatment Demonstrated Greater Viral Load,Reduction Compared to Adefovir at 48 Weeks in Study of,Antiviral-Naive Chronic Hepatitis B E-Antigen Positive Patients 6 Five Days of LEVAQUIN(R) as Effective as 10 Days of Ciprofloxacin,in Complicated Urinary Tract Infections and Acute Pyelonephritis 2 Five Days of LEVAQUIN(R) as Effective as 10 Days of Ciprofloxacin,in Complicated Urinary Tract Infections and Acute Pyelonephritis 3 Five Days of LEVAQUIN(R) as Effective as 10 Days of Ciprofloxacin,in Complicated Urinary Tract Infections and Acute Pyelonephritis 4

Baraclude (Entecavir) Treatment Demonstrated Greater Viral Load,Reduction Compared to Adefovir at 48 Weeks in Study of,Antiviral-Naive Chronic Hepatitis B E-Antigen Positive Patients Five Days of LEVAQUIN(R) as Effective as 10 Days of Ciprofloxacin,in Complicated Urinary Tract Infections and Acute Pyelonephritis

(Date:10/10/2008)...Study suggests poor self-care partly to blame , ... group of Medicare beneficiaries who have diabetes...th rate, according to a new study. , Publishi... Internal Medicine , researchers from the Universi...ries (average age of 75.6 years) who had diabetes ...

(Date:10/10/2008)...Finding suggests need for more careful screening f...RIDAY, Oct. 10 (HealthDay News) -- Patients coping...risk for developing colorectal cancer sometime in ... syndrome is a conglomeration of three or four dis... for certain illnesses, including a number of canc...

(Date:10/10/2008)... Honoring excellence in t...Rs), the Healthcare Information and Management Sys...he 2008 Davies Awards in the Organizational, Ambul.... , Chicago, IL (PRWEB) O...ementation of electronic health records (EHRs), th...

(Date:10/10/2008)..., ANN ARBOR, Mich.---The University of Michigan ...f Health to develop the world,s leading resource o...ng compounds that will ultimately take computer-ai...will house the data needed to improve computer pro...ial new drugs, said Heather Carlson, associate pro...

Breaking Medicine News(10 mins):Health News:Older Diabetics With Depression Face Higher Death Rate 2 Health News:Metabolic Syndrome Raises Colon Cancer Risk 75% 2 Health News:Metabolic Syndrome Raises Colon Cancer Risk 75% 3 Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 2 Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 3 Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 4 Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 5 Health News:U-M to house leading drug database 2

[0] Older Diabetics With Depression Face Higher Death Rate [0] Metabolic Syndrome Raises Colon Cancer Risk 75%[0] 2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized [0] U-M to house leading drug database

...age and gender were among the best indicators of h...release of the first comprehensive state-by-state ...o can say a lot about which and how many medicatio... the percentage of adult beneficiaries obtaining a...

...nce suggests that an air pollutant emitted by powe...er.City living can increase your chances of dying ...its are particles of air pollution. The study auth...rea exposes you to "fine particulate matter" that ...

...ries' entry into the global anti-acne market is li...the US Food and Drug Administration (US FDA) for t...n) for the generic isotretinoin has been postponed... arrived. The US FDA has already approved its man...

... the university of Michigan state that Women who s...ore likely than nonsmokers to give birth// to a ba...th defect rises with the number of cigarettes that...rs like the mother's race, age and educational lev...

Other Medicine News:Health News:Prescription Drug Use Varies Widely Between States 2

Prescription Drug Use Varies Widely Between States Air pollution may raise risk of lung cancer Ranbaxy Labs' Entry Into Anti-Acne Market Smoking during pregnancy increases risk of cleft palate

A necessary addition to any Trial Lens set, the Reichert Trial Frame provides a comfortable fit and smooth controls for quick, easy lens fitting.,The robust design, high-quality materials, and p

...e Advantage Chair and Stand is one of the most com...e, yet it does not compromise on modern ergonomic ...e mechanical components.,The Advantage manual...essional who demands the very best in patient comf...

...e Reichert ML1 Manual Lensometer combines the trad... advantages, such as LED illumination and cord-fre...icient LED light source provides a clear green ill...peration.,Battery operated and completely cor...

...e AL500 incorporates all of the features you would...isplay, auto add-lock, built-in printer, and more.... your existing workspace, while the tilting color ...gle.,Quick and accurate, the AL500 provides r...

Medicine Products:

Trial Frame Advantage Chair & Stand ML1 Manual LENSOMETER AL500 Auto LENSOMETER

( t of excessive sleepiness that is in a ...)Vanda Pharmaceuticals to Present Data on Iloperidone at the 2007,American Psychiatric Association Annual Meeting,Health